Stay updated on GMI-1359 Safety in HR+ Metastatic Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the GMI-1359 Safety in HR+ Metastatic Breast Cancer Clinical Trial page.

Latest updates to the GMI-1359 Safety in HR+ Metastatic Breast Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 is now shown on the page, replacing Revision: v3.4.1. This appears to be a minor behind-the-scenes update with no user-facing content changes.SummaryDifference0.1%

- Check20 days agoChange DetectedMinor site revision updated from v3.4.0 to v3.4.1; no changes to study content or critical information, and the layout remains the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedAdded a glossary toggle and updated metadata labels (capitalization and revision version).SummaryDifference0.3%

- Check42 days agoChange DetectedRevision tag updated from v3.3.3 to v3.3.4, a minor metadata change with no impact on study data or page layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page now includes a Locations section with North Carolina; the previous North Carolina Locations entry and HHS Vulnerability Disclosure were removed, and the revision was updated to v3.3.3.SummaryDifference0.3%

- Check91 days agoChange DetectedPage revision label updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to GMI-1359 Safety in HR+ Metastatic Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GMI-1359 Safety in HR+ Metastatic Breast Cancer Clinical Trial page.